These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 37842727)

  • 1. Recent Advances in the Pathogenesis and Clinical Evaluation of Portal Hypertension in Chronic Liver Disease.
    Kotani K; Kawada N
    Gut Liver; 2024 Jan; 18(1):27-39. PubMed ID: 37842727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and a Rational Basis of Therapy.
    Gracia-Sancho J; Maeso-Díaz R; Bosch J
    Dig Dis; 2015; 33(4):508-14. PubMed ID: 26159267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension.
    Afdhal N; Everson GT; Calleja JL; McCaughan GW; Bosch J; Brainard DM; McHutchison JG; De-Oertel S; An D; Charlton M; Reddy KR; Asselah T; Gane E; Curry MP; Forns X
    J Viral Hepat; 2017 Oct; 24(10):823-831. PubMed ID: 28295923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension.
    Lens S; Baiges A; Alvarado-Tapias E; LLop E; Martinez J; Fortea JI; Ibáñez-Samaniego L; Mariño Z; Rodríguez-Tajes S; Gallego A; Bañares R; Puente Á; Albillos A; Calleja JL; Torras X; Hernández-Gea V; Bosch J; Villanueva C; García-Pagán JC; Forns X
    J Hepatol; 2020 Dec; 73(6):1415-1424. PubMed ID: 32535060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of betablocked patients after sustained virological response in hepatitis C cirrhosis.
    Abadía M; Montes ML; Ponce D; Froilán C; Romero M; Poza J; Hernández T; Fernández-Martos R; Olveira A;
    World J Gastroenterol; 2019 Jun; 25(21):2665-2674. PubMed ID: 31210717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis.
    Kotani K; Enomoto M; Uchida-Kobayashi S; Tamori A; Yukawa-Muto Y; Odagiri N; Motoyama H; Kozuka R; Kawamura E; Hagihara A; Fujii H; Kageyama K; Yamamoto A; Yoshida A; Higashiyama S; Kawabe J; Kawada N
    J Gastroenterol; 2023 Apr; 58(4):394-404. PubMed ID: 36729172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive assessment of fibrosis regression and portal hypertension in patients with advanced chronic hepatitis C virus (HCV)-associated liver disease and sustained virologic response (SVR): 3 years follow-up of a prospective longitudinal study.
    Knop V; Hoppe D; Vermehren J; Troetschler S; Herrmann E; Vermehren A; Friedrich-Rust M; Sarrazin C; Trebicka J; Zeuzem S; Welker MW
    J Viral Hepat; 2021 Nov; 28(11):1604-1613. PubMed ID: 34342081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of etiological treatment on prognosis.
    Su CW; Yang YY; Lin HC
    Hepatol Int; 2018 Feb; 12(Suppl 1):56-67. PubMed ID: 28702738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleos(t)ide Analogs Do Not Independently Influence Hepatic Fibrosis and Portal Hypertension beyond Viral Suppression in CBDL-Induced Cirrhotic Rat.
    Hsieh YH; Huang HC; Chang CC; Chuang CL; Lee FY; Hsu SJ; Huang YH; Hou MC; Lee SD
    J Pharmacol Exp Ther; 2018 Nov; 367(2):260-266. PubMed ID: 30194095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of portal hypertension.
    Iwakiri Y
    Clin Liver Dis; 2014 May; 18(2):281-91. PubMed ID: 24679494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?
    Thabut D; Shah V
    J Hepatol; 2010 Nov; 53(5):976-80. PubMed ID: 20800926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hepatitis C oral therapy in portal hypertension.
    Libânio D; Marinho RT
    World J Gastroenterol; 2017 Jul; 23(26):4669-4674. PubMed ID: 28765688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperdynamic circulation in patients with liver cirrhosis and portal hypertension].
    Kim MY; Baik SK
    Korean J Gastroenterol; 2009 Sep; 54(3):143-8. PubMed ID: 19844149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Severe Portal Hypertension and Risk of Liver Decompensation in Patients With Hepatitis C, Regardless of Response to Antiviral Therapy.
    Lens S; Rincón D; García-Retortillo M; Albillos A; Calleja JL; Bañares R; Abraldes JG; Bosch J; Sanchez-Tapias JM; Forns X; García-Pagán JC
    Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1846-1853.e1. PubMed ID: 25912838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension.
    Manolakopoulos S; Triantos C; Theodoropoulos J; Vlachogiannakos J; Kougioumtzan A; Papatheodoridis G; Tzourmakliotis D; Karamanolis D; Burroughs AK; Archimandritis A; Raptis S; Avgerinos A
    J Hepatol; 2009 Sep; 51(3):468-74. PubMed ID: 19616339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses.
    Mandorfer M; Kozbial K; Freissmuth C; Schwabl P; Stättermayer AF; Reiberger T; Beinhardt S; Schwarzer R; Trauner M; Ferlitsch A; Hofer H; Peck-Radosavljevic M; Ferenci P
    Aliment Pharmacol Ther; 2015 Sep; 42(6):707-18. PubMed ID: 26179884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.
    Iwakiri Y; Shah V; Rockey DC
    J Hepatol; 2014 Oct; 61(4):912-24. PubMed ID: 24911462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic Changes in Non-Invasive Markers of Liver Fibrosis Are Predictors of Liver Events after SVR in HCV Patients.
    Fernández-Alvarez P; Guerra-Veloz MF; Vilches-Arenas A; Cordero-Ruíz P; Bellido-Muñoz F; Caunedo-Alvarez A; Carmona-Soria I
    Viruses; 2023 May; 15(6):. PubMed ID: 37376551
    [No Abstract]   [Full Text] [Related]  

  • 19. [Strategy for diagnosis and precise treatment of portal hypertension with hepatic venous pressure gradient: a dream or a reality?].
    Li Y; Li P; Zhang YN; Ding HG
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):254-258. PubMed ID: 29996334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.
    Lens S; Alvarado-Tapias E; Mariño Z; Londoño MC; LLop E; Martinez J; Fortea JI; Ibañez L; Ariza X; Baiges A; Gallego A; Bañares R; Puente A; Albillos A; Calleja JL; Torras X; Hernández-Gea V; Bosch J; Villanueva C; Forns X; García-Pagán JC
    Gastroenterology; 2017 Nov; 153(5):1273-1283.e1. PubMed ID: 28734831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.